| scholarly article | Q13442814 |
| P2093 | author name string | Anders Olsson | |
| Lisa U Magnusson | |||
| Jan-Erik Damber | |||
| Karin Welén | |||
| Pascale Plas | |||
| Malin Hagberg Thulin | |||
| P2860 | cites work | S100A9 interaction with TLR4 promotes tumor growth | Q21134707 |
| Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides | Q21145828 | ||
| Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors | Q21245714 | ||
| Global cancer statistics | Q22241238 | ||
| Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche | Q24606366 | ||
| Tasquinimod Is an Allosteric Modulator of HDAC4 survival signaling within the compromised cancer microenvironment | Q24618224 | ||
| Myeloid-derived suppressor cells: linking inflammation and cancer | Q24641811 | ||
| Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein | Q24641894 | ||
| Inflammation and cancer | Q24649640 | ||
| Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells | Q24658240 | ||
| Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 | ||
| Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study | Q28275476 | ||
| Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis | Q28275735 | ||
| HDAC4 represses matrix metalloproteinase-13 transcription in osteoblastic cells, and parathyroid hormone controls this repression | Q28582316 | ||
| Osteoblastic cells regulate the haematopoietic stem cell niche | Q29615007 | ||
| Identification of the haematopoietic stem cell niche and control of the niche size | Q29615008 | ||
| Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment | Q30304016 | ||
| Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance | Q30500080 | ||
| Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1. | Q33692449 | ||
| HDAC4 integrates PTH and sympathetic signaling in osteoblasts | Q33797044 | ||
| Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts. | Q34072879 | ||
| Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer | Q34217642 | ||
| Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050). | Q34250496 | ||
| Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer | Q34563829 | ||
| The quinoline-3-carboxamide anti-angiogenic agent, tasquinimod, enhances the anti-prostate cancer efficacy of androgen ablation and taxotere without effecting serum PSA directly in human xenografts | Q34610434 | ||
| Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow | Q34755120 | ||
| The class II histone deacetylase HDAC4 regulates cognitive, metabolic and endocrine functions through its expression in osteoblasts | Q35040485 | ||
| Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models | Q35071167 | ||
| Myeloid-derived suppressor cells regulate natural killer cell response to adenovirus-mediated gene transfer | Q36414429 | ||
| The RANK/RANKL/OPG triad in cancer-induced bone diseases | Q36688664 | ||
| LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis | Q36903532 | ||
| The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites | Q37096553 | ||
| Cadherin-11 promotes the metastasis of prostate cancer cells to bone | Q37100123 | ||
| Osteoblasts stimulate the osteogenic and metastatic progression of castration-resistant prostate cancer in a novel model for in vitro and in vivo studies | Q37558837 | ||
| Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation | Q37594369 | ||
| Paradoxical roles of IL-4 in tumor immunity | Q37651680 | ||
| Premetastatic niche: ready for new therapeutic interventions? | Q37996455 | ||
| The rationale for targeting the LOX family in cancer | Q38027412 | ||
| Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial | Q38212374 | ||
| Lysyl oxidase (lox) gene deficiency affects osteoblastic phenotype. | Q39224283 | ||
| N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer | Q39726974 | ||
| Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1. | Q39763199 | ||
| Altered expression of genes regulating angiogenesis in experimental androgen-independent prostate cancer | Q40036320 | ||
| Long-term Safety and Antitumor Activity in the Phase 1-2 Study of Enzalutamide in Pre- and Post-docetaxel Castration-Resistant Prostate Cancer | Q41029729 | ||
| G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow | Q41788910 | ||
| Tasquinimod prevents the angiogenic rebound induced by fractionated radiation resulting in an enhanced therapeutic response of prostate cancer xenografts | Q41836745 | ||
| Molecular mechanisms of the inhibitory effect of lipopolysaccharide (LPS) on osteoblast differentiation | Q42841776 | ||
| Hematopoietic stem cells do not depend on N-cadherin to regulate their maintenance | Q43129066 | ||
| S100A8/S100A9 and their association with cartilage and bone | Q46279555 | ||
| Cell-to-cell contact is critical for the survival of hematopoietic progenitor cells on osteoblasts. | Q51328919 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 383-393 | |
| P577 | publication date | 2015-12-10 | |
| P1433 | published in | The Prostate | Q7758608 |
| P1476 | title | Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment | |
| P478 | volume | 76 |
| Q28072232 | Cell and Signal Components of the Microenvironment of Bone Metastasis Are Affected by Hypoxia |
| Q26748872 | Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review |
| Q40468733 | Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial. |
Search more.